$MMI
Marcus & Millichap, Inc. Stock $mmi

$mmi Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000157873223000021 Filed on May 05, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q4
Revenue	$162.9M	$154.8M	$262.4M
YoY Change	-58.87%	-51.55%	-46.99%
Cost Of Revenue	$101.2M	$95.43M	$180.7M
YoY Change	-60.49%	-51.5%	-45.78%
Gross Profit	$61.70M	$59.37M	$81.73M
YoY Change	-55.9%	-51.62%	-49.49%
Gross Profit Margin	37.89%	38.35%	31.14%
Selling, General & Admin	$68.91M	$72.22M	$72.63M
YoY Change	-13.69%	-3.11%	-5.69%
% of Gross Profit	111.68%	121.65%	88.87%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$3.468M	$2.000M	$3.239M
YoY Change	92.67%	-48.86%	11.11%
% of Gross Profit	5.62%	3.37%	3.96%
Operating Expenses	$72.38M	$170.9M	$75.87M
YoY Change	-78.66%	117.8%	-5.07%
Operating Profit	-$10.68M	-$16.06M	$5.857M
YoY Change	-118.81%	-136.3%	-92.85%
Interest Expense	-$216.0K	$215.0K	-$161.0K
YoY Change	-236.71%	-234.38%	11.81%
% of Operating Profit			-2.75%
Other Income/Expense, Net	$4.890M	$4.810M	$4.369M
YoY Change	-1160.74%	968.89%	144.08%
Pretax Income	-$6.001M	-$11.47M	$10.07M
YoY Change	-110.69%	-125.74%	-87.95%
Income Tax	$2.728M	-$5.633M	$2.153M
% Of Pretax Income			21.39%
Net Earnings	-$8.729M	-$5.833M	$7.912M
YoY Change	-120.7%	-117.79%	-87.24%
Net Earnings / Revenue	-5.36%	-3.77%	3.01%
Basic Earnings Per Share	-$0.23	-$0.15
Diluted Earnings Per Share	-$0.23	-$0.15	$0.20
COMMON SHARES
Basic Shares Outstanding	38.48M shares	39.24M shares	39.37M shares
Diluted Shares Outstanding	38.54M shares	39.20M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$336.1M	$360.5M	$489.3M
YoY Change	-27.68%	-32.57%	-13.55%
Cash & Equivalents	$171.2M	$228.0M	$235.9M
Short-Term Investments	$164.9M	$132.5M	$253.4M
Other Short-Term Assets	$18.22M	$5.052M	$7.282M
YoY Change	209.85%	-77.33%	38.18%
Inventory
Prepaid Expenses	$8.872M	$8.740M	$9.411M
Receivables
Other Receivables
Total Short-Term Assets	$381.7M	$405.2M	$527.1M
YoY Change	-23.4%	-29.01%	-13.32%
LONG-TERM ASSETS
Property, Plant & Equipment	$131.2M	$28.22M	$27.64M
YoY Change	417.81%	-72.11%	19.2%
Goodwill	$38.05M	$37.93M	$37.91M
YoY Change	-0.14%	848.28%	11.28%
Intangibles
YoY Change
Long-Term Investments	$81.08M	$80.45M	$78.15M
YoY Change	-7.0%	25.9%	-37.04%
Other Assets	$236.0M	$17.29M	$15.86M
YoY Change	1638.52%	-90.64%	20.64%
Total Long-Term Assets	$501.8M	$505.3M	$476.6M
YoY Change	7.12%	23.44%	9.04%
TOTAL ASSETS
Total Short-Term Assets	$381.7M	$405.2M	$527.1M
Total Long-Term Assets	$501.8M	$505.3M	$476.6M
Total Assets	$883.5M	$910.5M	$1.004B
YoY Change	-8.61%	-7.11%	-3.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$11.89M	$12.39M	$11.45M
YoY Change	-8.67%	-49.19%	-52.82%
Accrued Expenses	$28.93M	$23.49M	$55.31M
YoY Change	-41.23%	-31.2%	-19.63%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$89.07M	$102.9M	$152.0M
YoY Change	-30.44%	-46.47%	-32.63%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$130.5M	$8.229M	$8.614M
YoY Change	1193.86%	-92.69%	-24.4%
Total Long-Term Liabilities	$130.5M	$8.229M	$8.614M
YoY Change	1193.86%	-92.69%	-24.4%
TOTAL LIABILITIES
Total Short-Term Liabilities	$89.07M	$102.9M	$152.0M
Total Long-Term Liabilities	$130.5M	$8.229M	$8.614M
Total Liabilities	$219.6M	$228.3M	$290.2M
YoY Change	-12.02%	-25.08%	-16.82%
SHAREHOLDERS EQUITY
Retained Earnings	$526.4M	$551.7M	$585.6M
YoY Change	-11.74%		2.1%
Common Stock	$140.1M	$132.9M	$131.5M
YoY Change	13.23%		7.96%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$663.9M	$682.2M	$713.5M
YoY Change
Total Liabilities & Shareholders Equity	$883.5M	$910.5M	$1.004B
YoY Change	-8.61%	-7.11%	-3.97%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q4
OPERATING ACTIVITIES
Net Income	-$8.729M	-$5.833M	$7.912M
YoY Change	-120.7%	-117.79%	-87.24%
Depreciation, Depletion And Amortization	$3.468M	$2.000M	$3.239M
YoY Change	92.67%	-48.86%	11.11%
Cash From Operating Activities	$6.432M	-$101.2M	$25.40M
YoY Change	-59.02%	49.86%	-83.75%
INVESTING ACTIVITIES
Capital Expenditures	$2.606M	$2.863M	$3.102M
YoY Change	-183.02%	-252.04%	-218.44%
Acquisitions		$0.00
YoY Change		-100.0%
Other Investing Activities	-$32.38M	$120.2M	-$19.58M
YoY Change	-46.41%	1255.96%	-60.8%
Cash From Investing Activities	-$34.98M	$117.4M	-$22.68M
YoY Change	-44.96%	1580.6%	-56.85%
FINANCING ACTIVITIES
Cash Dividend Paid		$441.0K
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-28.36M	-$24.02M	-37.78M
YoY Change	-49.32%	304.09%	-23421.6%
NET CHANGE
Cash From Operating Activities	6.432M	-$101.2M	25.40M
Cash From Investing Activities	-34.98M	$117.4M	-22.68M
Cash From Financing Activities	-28.36M	-$24.02M	-37.78M
Net Change In Cash	-56.91M	-$7.847M	-35.06M
YoY Change	-45.19%	-88.2%	-133.75%
FREE CASH FLOW
Cash From Operating Activities	$6.432M	-$101.2M	$25.40M
Capital Expenditures	$2.606M	$2.863M	$3.102M
Free Cash Flow	$3.826M	-$104.1M	$22.30M
YoY Change	-79.69%	58.52%	-85.97%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001578732
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-36155
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	MARCUS & MILLICHAP, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	35-2478370
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	23975 Park Sorrento, Suite 400
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Calabasas
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	91302
CY2023Q1	dei	City Area Code CityAreaCode	818
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	212-2250
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
CY2023Q1	dei	Trading Symbol TradingSymbol	MMI
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	38476404	shares
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	228026000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	235873000	usd
CY2023Q1	mmi	Commissions Receivable Net Current CommissionsReceivableNetCurrent	9782000	usd
CY2022Q4	mmi	Commissions Receivable Net Current CommissionsReceivableNetCurrent	8453000	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	8740000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	9411000	usd
CY2023Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	18053000	usd
CY2022Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	8682000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	133178000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	254682000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Current DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent	0	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Current DebtSecuritiesAvailableForSaleAllowanceForCreditLossCurrent	0	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	132520000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	253434000	usd
CY2023Q1	mmi	Advances And Loans Net Current AdvancesAndLoansNetCurrent	3045000	usd
CY2022Q4	mmi	Advances And Loans Net Current AdvancesAndLoansNetCurrent	4005000	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	5052000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	7282000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	405218000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	527140000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	28223000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	27644000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	107891000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	87945000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Amortized Cost Noncurrent DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent	73823000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Noncurrent DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent	72819000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Noncurrent DebtSecuritiesAvailableForSaleAllowanceForCreditLossNoncurrent	0	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Allowance For Credit Loss Noncurrent DebtSecuritiesAvailableForSaleAllowanceForCreditLossNoncurrent	0	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	70493000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	68595000	usd
CY2023Q1	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	9953000	usd
CY2022Q4	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	9553000	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	37427000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	41321000	usd
CY2023Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	54551000	usd
CY2022Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	55696000	usd
CY2023Q1	mmi	Advances And Loans Net Non Current AdvancesAndLoansNetNonCurrent	179443000	usd
CY2022Q4	mmi	Advances And Loans Net Non Current AdvancesAndLoansNetNonCurrent	169955000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	17293000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	15859000	usd
CY2023Q1	us-gaap	Assets Assets	910492000	usd
CY2022Q4	us-gaap	Assets Assets	1003708000	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	12392000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	11450000	usd
CY2023Q1	mmi	Deferred Compensation And Commissions Current DeferredCompensationAndCommissionsCurrent	46253000	usd
CY2022Q4	mmi	Deferred Compensation And Commissions Current DeferredCompensationAndCommissionsCurrent	75321000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	16911000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	16984000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6578000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	38327000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	20781000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	9933000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	102915000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	152015000	usd
CY2023Q1	mmi	Deferred Compensation And Commissions Non Current DeferredCompensationAndCommissionsNonCurrent	34422000	usd
CY2022Q4	mmi	Deferred Compensation And Commissions Non Current DeferredCompensationAndCommissionsNonCurrent	64461000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	82768000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	65109000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8229000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8614000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	228334000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	290199000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38876354	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	38876354	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	39255838	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	39255838	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	4000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	4000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	132905000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	131541000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	551696000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	585581000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2447000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3617000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	682158000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	713509000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	910492000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1003708000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	154792000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	319464000	usd
CY2023Q1	mmi	Services Cost ServicesCost	95427000	usd
CY2022Q1	mmi	Services Cost ServicesCost	196768000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	72219000	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	74535000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3207000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3911000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	170853000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	275214000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-16061000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	44250000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4810000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	450000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	215000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	160000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11466000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	44540000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-5633000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	11757000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-5833000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	32783000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.82
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.81
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39200000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39989000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39200000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40474000	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-5833000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	32783000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	1116000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-2357000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	0	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	84000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	366000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	-838000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	1116000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-2441000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	54000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-59000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1170000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2500000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4663000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	30283000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	713509000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4663000	usd
CY2023Q1	us-gaap	Dividends Common Stock DividendsCommonStock	10284000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	5011000	usd
CY2023Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	3647000	usd
CY2023Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	17768000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	682158000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	696304000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	30283000	usd
CY2022Q1	us-gaap	Dividends Common Stock DividendsCommonStock	52136000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	3856000	usd
CY2022Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	2918000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	675389000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-5833000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	32783000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3207000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3911000	usd
CY2023Q1	mmi	Noncash Lease Expense NoncashLeaseExpense	6003000	usd
CY2022Q1	mmi	Noncash Lease Expense NoncashLeaseExpense	5961000	usd
CY2023Q1	mmi	Credit Loss Expense Reversal CreditLossExpenseReversal	-1000	usd
CY2022Q1	mmi	Credit Loss Expense Reversal CreditLossExpenseReversal	-167000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	5011000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3856000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3529000	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1104000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-65000	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	151000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	0	usd
CY2022Q1	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	113000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-52000	usd
CY2022Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-11000	usd
CY2023Q1	mmi	Increase Decrease In Commissions Receivable IncreaseDecreaseInCommissionsReceivable	1318000	usd
CY2022Q1	mmi	Increase Decrease In Commissions Receivable IncreaseDecreaseInCommissionsReceivable	-3430000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-671000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-2850000	usd
CY2023Q1	mmi	Increase Decrease In Advances And Loans IncreaseDecreaseInAdvancesAndLoans	8271000	usd
CY2022Q1	mmi	Increase Decrease In Advances And Loans IncreaseDecreaseInAdvancesAndLoans	25084000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	2961000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	794000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2390000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1308000	usd
CY2023Q1	mmi	Increase Decrease In Income Taxes Receivable Payable IncreaseDecreaseInIncomeTaxesReceivablePayable	9371000	usd
CY2022Q1	mmi	Increase Decrease In Income Taxes Receivable Payable IncreaseDecreaseInIncomeTaxesReceivablePayable	-10189000	usd
CY2023Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-31750000	usd
CY2022Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-33990000	usd
CY2023Q1	mmi	Deferred Compensation And Commissions Increase Decrease DeferredCompensationAndCommissionsIncreaseDecrease	-57605000	usd
CY2022Q1	mmi	Deferred Compensation And Commissions Increase Decrease DeferredCompensationAndCommissionsIncreaseDecrease	-65384000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-4571000	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-5031000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-454000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-2224000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-101207000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-67535000	usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2022Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	12500000	usd
CY2023Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	67042000	usd
CY2022Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	40551000	usd
CY2023Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	187258000	usd
CY2022Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	61970000	usd
CY2023Q1	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	10000	usd
CY2022Q1	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	71000	usd
CY2023Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	13000	usd
CY2022Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	18000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2863000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1883000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	117356000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	6983000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3647000	usd
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2918000	usd
CY2023Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	441000	usd
CY2022Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	0	usd
CY2023Q1	mmi	Payments On Stock Appreciation Rights PaymentsOnStockAppreciationRights	1945000	usd
CY2022Q1	mmi	Payments On Stock Appreciation Rights PaymentsOnStockAppreciationRights	1761000	usd
CY2023Q1	mmi	Principal Payments On Deferred And Contingent Consideration PrincipalPaymentsOnDeferredAndContingentConsideration	1283000	usd
CY2022Q1	mmi	Principal Payments On Deferred And Contingent Consideration PrincipalPaymentsOnDeferredAndContingentConsideration	1264000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	16699000	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-24015000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5943000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	50000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-7847000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-66445000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	235873000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	382140000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	228026000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	315695000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	393000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	499000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	209000	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	464000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	510000	usd
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	406000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	25910000	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	7771000	usd
CY2023Q1	mmi	Measurement Period Adjustment Of Acquisition Related Contingent Consideration MeasurementPeriodAdjustmentOfAcquisitionRelatedContingentConsideration	0	usd
CY2022Q1	mmi	Measurement Period Adjustment Of Acquisition Related Contingent Consideration MeasurementPeriodAdjustmentOfAcquisitionRelatedContingentConsideration	66000	usd
CY2023Q1	mmi	Number Of Offices NumberOfOffices	80	office
CY2023Q1	mmi	Percentage Of Common Stock Distributed PercentageOfCommonStockDistributed	0.800
CY2022	mmi	Available For Sale Securities Weighted Average Maturity AvailableForSaleSecuritiesWeightedAverageMaturity	P1Y1M6D
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the related disclosures at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
CY2023Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to a concentration of credit risk principally consist of cash, cash equivalents, and restricted cash, investments in marketable debt securities, available-for-sale, security deposits (included under other assets, non-current) and commissions receivable, net. Cash, cash equivalents, and restricted cash are placed with high-credit quality financial institutions and invested in high-credit quality money market funds and commercial paper. Concentrations and ratings of marketable debt securities, available-for-sale are limited by the approved investment policy. </span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To reduce its credit risk, the Company monitors the credit standing of the financial institutions money market funds that represent amounts recorded as cash, cash equivalents, and restricted cash. The Company historically has not experienced any significant losses related to cash, cash equivalents, and restricted cash. </span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, the Company entered into a Strategic Alliance (“Strategic Alliance”) with M&T Realty Capital Corporation (“MTRCC”) pursuant to which the Company has agreed to provide loan opportunities that may be funded through MTRCC’s Delegated Underwriting and Servicing Agreement (“DUS Agreement”) with the Federal National Mortgage Association (“Fannie Mae”) that requires MTRCC to guarantee a portion of each loan funded. On a loan-by-loan basis, the Company, at its option, can indemnify a portion of MTRCC’s guarantee obligation of loan opportunities presented to and closed by MTRCC through the DUS Agreement. The Company manages and limits the concentration of risk related to the guarantees assumed by monitoring the underlying property type, geographic location, credit of the borrowers, underlying debt service coverage, and loan to value ratios.</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company derives its revenue from a broad range of real estate investors, owners, and users in the United States and Canada, none of which individually represents a significant concentration of credit risk. The Company maintains allowances, as needed, for estimated credit losses based on management’s assessment of the likelihood of collection. For the three months ended March 31, 2023 and 2022, no transaction represented 10% or more of total revenue. Further, while one or more transactions may represent 10% or more of commissions receivable at any reporting date, amounts due are typically collected within 10 days of settlement and, therefore, do not expose the Company to significant credit risk. </span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2023 and 2022, the Company’s Canadian operations represented 2.9% and 2.2% of total revenue, respectively. </span></div>During each of the three months ended March 31, 2023 and 2022, no office represented 10% or more of total revenue.
CY2023Q1	mmi	Period Of Settlement For Receivable Balances PeriodOfSettlementForReceivableBalances	P10D
CY2023Q1	us-gaap	Guarantee Obligations Liquidation Proceeds Percentage GuaranteeObligationsLiquidationProceedsPercentage	0.167
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	43469000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	41426000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	28223000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	27644000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	2000000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	1900000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	125155000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	1265000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	40014000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	2818000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	165169000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	4083000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	209028000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	3501000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	79003000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	2007000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	288031000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	5508000	usd
CY2023Q1	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	reportingunit
CY2023Q1	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	0	usd
CY2022Q1	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	113000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	0	usd
CY2022Q1	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	0	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	133179000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	132520000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	254683000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	253434000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	55922000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	54034000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	56507000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	54169000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	14067000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	12867000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	13435000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	11850000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	3833000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	3592000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	2876000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	2576000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	207001000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	203013000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	327501000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	322029000	usd
CY2023Q1	mmi	Available For Sale Securities Weighted Average Maturity AvailableForSaleSecuritiesWeightedAverageMaturity	P1Y10M24D
CY2023Q1	us-gaap	Goodwill Gross GoodwillGross	37931000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	37931000	usd
CY2022Q4	us-gaap	Goodwill Gross GoodwillGross	37914000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	37914000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	32304000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	15684000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	16620000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	32287000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	14505000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	17782000	usd
CY2023Q1	mmi	Intangible Assets Gross Including Goodwill IntangibleAssetsGrossIncludingGoodwill	70235000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	15684000	usd
CY2023Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	54551000	usd
CY2022Q4	mmi	Intangible Assets Gross Including Goodwill IntangibleAssetsGrossIncludingGoodwill	70201000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	14505000	usd
CY2022Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	55696000	usd
CY2023Q1	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P4Y1M6D
CY2022	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P4Y6M
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1200000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1200000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	37914000	usd
CY2023Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	usd
CY2023Q1	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	17000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	37931000	usd
CY2022Q1	us-gaap	Goodwill Goodwill	4000000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	3435000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths	4091000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Two FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo	3873000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Three FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree	2156000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Four FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour	1736000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1329000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	16620000	usd
CY2023Q1	mmi	Advances And Loans And Commissions Receivable Allowance For Credit Loss AdvancesAndLoansAndCommissionsReceivableAllowanceForCreditLoss	848000	usd
CY2022Q4	mmi	Advances And Loans And Commissions Receivable Allowance For Credit Loss AdvancesAndLoansAndCommissionsReceivableAllowanceForCreditLoss	791000	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	5052000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	7282000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	17293000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	15859000	usd
CY2023Q1	mmi	Treasury Note Rate Term TreasuryNoteRateTerm	P1Y
CY2023Q1	mmi	Stock Appreciation Rights Liability Current StockAppreciationRightsLiabilityCurrent	2480000	usd
CY2022Q4	mmi	Stock Appreciation Rights Liability Current StockAppreciationRightsLiabilityCurrent	2323000	usd
CY2023Q1	mmi	Stock Appreciation Rights Liability Noncurrent StockAppreciationRightsLiabilityNoncurrent	10847000	usd
CY2022Q4	mmi	Stock Appreciation Rights Liability Noncurrent StockAppreciationRightsLiabilityNoncurrent	13137000	usd
CY2023Q1	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	42648000	usd
CY2022Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	72247000	usd
CY2023Q1	mmi	Accrued Sales Commission Non Current AccruedSalesCommissionNonCurrent	16384000	usd
CY2022Q4	mmi	Accrued Sales Commission Non Current AccruedSalesCommissionNonCurrent	45156000	usd
CY2023Q1	us-gaap	Deferred Compensation Cash Based Arrangements Liability Current DeferredCompensationCashBasedArrangementsLiabilityCurrent	527000	usd
CY2022Q4	us-gaap	Deferred Compensation Cash Based Arrangements Liability Current DeferredCompensationCashBasedArrangementsLiabilityCurrent	493000	usd
CY2023Q1	us-gaap	Deferred Compensation Cashbased Arrangements Liability Classified Noncurrent DeferredCompensationCashbasedArrangementsLiabilityClassifiedNoncurrent	7191000	usd
CY2022Q4	us-gaap	Deferred Compensation Cashbased Arrangements Liability Classified Noncurrent DeferredCompensationCashbasedArrangementsLiabilityClassifiedNoncurrent	6168000	usd
CY2023Q1	us-gaap	Other Deferred Compensation Arrangements Liability Current OtherDeferredCompensationArrangementsLiabilityCurrent	598000	usd
CY2022Q4	us-gaap	Other Deferred Compensation Arrangements Liability Current OtherDeferredCompensationArrangementsLiabilityCurrent	258000	usd
CY2023Q1	us-gaap	Other Deferred Compensation Arrangements Liability Classified Noncurrent OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent	0	usd
CY2022Q4	us-gaap	Other Deferred Compensation Arrangements Liability Classified Noncurrent OtherDeferredCompensationArrangementsLiabilityClassifiedNoncurrent	0	usd
CY2023Q1	mmi	Deferred Compensation And Commissions Current DeferredCompensationAndCommissionsCurrent	46253000	usd
CY2022Q4	mmi	Deferred Compensation And Commissions Current DeferredCompensationAndCommissionsCurrent	75321000	usd
CY2023Q1	mmi	Deferred Compensation And Commissions Non Current DeferredCompensationAndCommissionsNonCurrent	34422000	usd
CY2022Q4	mmi	Deferred Compensation And Commissions Non Current DeferredCompensationAndCommissionsNonCurrent	64461000	usd
CY2023Q1	mmi	Increase Decrease In Carrying Value Of Assets Held In Rabbi Trust IncreaseDecreaseInCarryingValueOfAssetsHeldInRabbiTrust	458000	usd
CY2022Q1	mmi	Increase Decrease In Carrying Value Of Assets Held In Rabbi Trust IncreaseDecreaseInCarryingValueOfAssetsHeldInRabbiTrust	-525000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	433000	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	-532000	usd
CY2023Q1	mmi	Deferred Consideration Liabilities Current DeferredConsiderationLiabilitiesCurrent	2323000	usd
CY2022Q4	mmi	Deferred Consideration Liabilities Current DeferredConsiderationLiabilitiesCurrent	3633000	usd
CY2023Q1	mmi	Deferred Consideration Liabilities Noncurrent DeferredConsiderationLiabilitiesNoncurrent	1510000	usd
CY2022Q4	mmi	Deferred Consideration Liabilities Noncurrent DeferredConsiderationLiabilitiesNoncurrent	1486000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	2256000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	1726000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	4787000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	5341000	usd
CY2023Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	10531000	usd
CY2022Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	612000	usd
CY2023Q1	mmi	Dividends Payable Non Current DividendsPayableNonCurrent	1528000	usd
CY2022Q4	mmi	Dividends Payable Non Current DividendsPayableNonCurrent	1603000	usd
CY2023Q1	mmi	Stock Repurchase Payable Current StockRepurchasePayableCurrent	1634000	usd
CY2022Q4	mmi	Stock Repurchase Payable Current StockRepurchasePayableCurrent	565000	usd
CY2023Q1	mmi	Stock Repurchase Payable Noncurrent StockRepurchasePayableNoncurrent	0	usd
CY2022Q4	mmi	Stock Repurchase Payable Noncurrent StockRepurchasePayableNoncurrent	0	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4037000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3397000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	404000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	184000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	20781000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	9933000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8229000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8614000	usd
CY2023Q1	us-gaap	Due From Employees DueFromEmployees	1000	usd
CY2022Q4	us-gaap	Due From Employees DueFromEmployees	6000	usd
CY2023Q1	mmi	Deferred Consideration Liabilities Current Noncurrent DeferredConsiderationLiabilitiesCurrentNoncurrent	3833000	usd
CY2022Q4	mmi	Deferred Consideration Liabilities Current Noncurrent DeferredConsiderationLiabilitiesCurrentNoncurrent	5119000	usd
CY2023Q1	us-gaap	Deferred Compensation Cashbased Arrangements Liability Current And Noncurrent DeferredCompensationCashbasedArrangementsLiabilityCurrentAndNoncurrent	7718000	usd
CY2022Q4	us-gaap	Deferred Compensation Cashbased Arrangements Liability Current And Noncurrent DeferredCompensationCashbasedArrangementsLiabilityCurrentAndNoncurrent	6661000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet	0	usd
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet	0	usd
CY2023Q1	mmi	Business Combination Contingent Deferred Consideration Arrangements Range Of Outcomes Value High BusinessCombinationContingentDeferredConsiderationArrangementsRangeOfOutcomesValueHigh	19600000	usd
CY2022Q4	mmi	Business Combination Contingent Deferred Consideration Arrangements Range Of Outcomes Value High BusinessCombinationContingentDeferredConsiderationArrangementsRangeOfOutcomesValueHigh	21300000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	7043000	usd
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	9363000	usd
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	38876354	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	38876354	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	39255838	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	39255838	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	0	usd
CY2022Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	70000000	usd
CY2023Q1	us-gaap	Treasury Stock Shares Retired TreasuryStockSharesRetired	559923	shares
CY2023Q1	us-gaap	Treasury Stock Retired Cost Method Amount TreasuryStockRetiredCostMethodAmount	17800000	usd
CY2023Q1	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	31.73
CY2023Q1	mmi	Stock Repurchase Payable Current StockRepurchasePayableCurrent	1600000	usd
CY2023Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	22600000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	3466957	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1741461	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	42.14
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	456028	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	35.78
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	293873	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	42.70
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	2821	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	41.54
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1900795	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	40.53
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	71400000	usd
CY2023Q1	mmi	Unrecognized Compensation Expense Is Expected To Be Recognized Over A Weighted Average Period Years UnrecognizedCompensationExpenseIsExpectedToBeRecognizedOverAWeightedAveragePeriodYears	P3Y10M17D
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5011000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3856000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.491
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.264
CY2023Q1	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2408000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022Q1	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	9353000	usd
CY2022Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2023Q1	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-739000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.064
CY2022Q1	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	2033000	usd
CY2022Q1	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.046
CY2023Q1	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	654000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.057
CY2022Q1	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-306000	usd
CY2022Q1	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.007
CY2023Q1	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	227000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.020
CY2022Q1	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-104000	usd
CY2022Q1	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.002
CY2023Q1	mmi	Income Tax Reconciliation Permanent And Other Items IncomeTaxReconciliationPermanentAndOtherItems	-3367000	usd
CY2023Q1	mmi	Effective Income Tax Rate On Permanent And Other Items EffectiveIncomeTaxRateOnPermanentAndOtherItems	0.294
CY2022Q1	mmi	Income Tax Reconciliation Permanent And Other Items IncomeTaxReconciliationPermanentAndOtherItems	781000	usd
CY2022Q1	mmi	Effective Income Tax Rate On Permanent And Other Items EffectiveIncomeTaxRateOnPermanentAndOtherItems	0.017
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-5633000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.491
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	11757000	usd
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.264
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-5833000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	32783000	usd
CY2023Q1	mmi	Change In Value Deferred Consideration Settled In Stock ChangeInValueDeferredConsiderationSettledInStock	-18000	usd
CY2022Q1	mmi	Change In Value Deferred Consideration Settled In Stock ChangeInValueDeferredConsiderationSettledInStock	63000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5815000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	32720000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	39211000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	39721000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	11000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	13000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Contingently Issuable WeightedAverageNumberOfSharesContingentlyIssuable	0	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Contingently Issuable WeightedAverageNumberOfSharesContingentlyIssuable	281000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39200000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39989000	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.82
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39200000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39989000	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	396000	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	0	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	89000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39200000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40474000	shares
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.81
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1608000	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	778000	shares
CY2023Q1	us-gaap	Guarantee Obligations Maximum Exposure GuaranteeObligationsMaximumExposure	89200000	usd
CY2023Q1	mmi	Maximum Unpaid Loan Amount For Which Guarantee Obligations Granted MaximumUnpaidLoanAmountForWhichGuaranteeObligationsGranted	535000000	usd
CY2023Q1	mmi	Guarantor Obligations Allowance For Loss Sharing Obligations GuarantorObligationsAllowanceForLossSharingObligations	496000	usd
CY2022Q4	mmi	Guarantor Obligations Allowance For Loss Sharing Obligations GuarantorObligationsAllowanceForLossSharingObligations	275000	usd
CY2023Q1	mmi	Guarantor Obligations Amount Pledged GuarantorObligationsAmountPledged	41000	usd
CY2022Q4	mmi	Guarantor Obligations Amount Pledged GuarantorObligationsAmountPledged	16000	usd
CY2023Q1	us-gaap	Other Commitment OtherCommitment	17700000	usd

Files In Submission

Name	View Source	Status
0001578732-23-000021-index-headers.html	Edgar Link	pending
0001578732-23-000021-index.html	Edgar Link	pending
0001578732-23-000021.txt	Edgar Link	pending
0001578732-23-000021-xbrl.zip	Edgar Link	pending
a10-qmmix20230331x10qxex311.htm	Edgar Link	pending
a10-qmmix20230331x10qxex312.htm	Edgar Link	pending
a10-qmmix20230331x10qxex321.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mmi-20230331.htm	Edgar Link	pending
mmi-20230331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
mmi-20230331_cal.xml	Edgar Link	unprocessable
mmi-20230331_def.xml	Edgar Link	unprocessable
mmi-20230331_lab.xml	Edgar Link	unprocessable
mmi-20230331_pre.xml	Edgar Link	unprocessable
mmi-20230331_htm.xml	Edgar Link	completed
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MMI
Marcus & Millichap, Inc. Stock $mmi

2023 Q2 Form 10-Q Financial Statement

#000157873223000021 Filed on May 05, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MMI Marcus & Millichap, Inc. Stock $mmi

2023 Q2 Form 10-Q Financial Statement

#000157873223000021 Filed on May 05, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MMI
Marcus & Millichap, Inc. Stock $mmi